JP2025536416A5 - - Google Patents

Info

Publication number
JP2025536416A5
JP2025536416A5 JP2025525056A JP2025525056A JP2025536416A5 JP 2025536416 A5 JP2025536416 A5 JP 2025536416A5 JP 2025525056 A JP2025525056 A JP 2025525056A JP 2025525056 A JP2025525056 A JP 2025525056A JP 2025536416 A5 JP2025536416 A5 JP 2025536416A5
Authority
JP
Japan
Prior art keywords
crystal
crystal form
diffraction pattern
ray powder
solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2025525056A
Other languages
English (en)
Japanese (ja)
Other versions
JP7866687B2 (ja
JP2025536416A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2023/131627 external-priority patent/WO2024104354A1/zh
Publication of JP2025536416A publication Critical patent/JP2025536416A/ja
Publication of JP2025536416A5 publication Critical patent/JP2025536416A5/ja
Application granted granted Critical
Publication of JP7866687B2 publication Critical patent/JP7866687B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2025525056A 2022-11-14 2023-11-14 置換ピペラジン誘導体の結晶およびその調製方法 Active JP7866687B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202211417721.3 2022-11-14
CN202211417721 2022-11-14
PCT/CN2023/131627 WO2024104354A1 (zh) 2022-11-14 2023-11-14 一种取代的哌嗪衍生物的晶体及其制备方法

Publications (3)

Publication Number Publication Date
JP2025536416A JP2025536416A (ja) 2025-11-05
JP2025536416A5 true JP2025536416A5 (cg-RX-API-DMAC7.html) 2026-04-10
JP7866687B2 JP7866687B2 (ja) 2026-05-27

Family

ID=90997576

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2025525056A Active JP7866687B2 (ja) 2022-11-14 2023-11-14 置換ピペラジン誘導体の結晶およびその調製方法

Country Status (9)

Country Link
US (1) US20250270223A1 (cg-RX-API-DMAC7.html)
EP (1) EP4620958A4 (cg-RX-API-DMAC7.html)
JP (1) JP7866687B2 (cg-RX-API-DMAC7.html)
KR (1) KR20250086779A (cg-RX-API-DMAC7.html)
CN (1) CN118027039A (cg-RX-API-DMAC7.html)
AU (1) AU2023381502A1 (cg-RX-API-DMAC7.html)
MX (1) MX2025005591A (cg-RX-API-DMAC7.html)
TW (1) TWI879228B (cg-RX-API-DMAC7.html)
WO (1) WO2024104354A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL326495A (en) * 2023-08-17 2026-04-01 Kangbaida Sichuan Biotechnology Co Ltd Pharmaceutical preparation of piperazine derivative, preparation method therefor, and use thereof
WO2025209574A1 (zh) * 2024-04-03 2025-10-09 康百达(四川)生物医药科技有限公司 用于预防或治疗肿瘤的parp7抑制剂

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112020022006A2 (pt) * 2018-04-30 2021-01-26 Ribon Therapeutics Inc. piridazinonas como inibidores de parp7
WO2020223229A1 (en) * 2019-04-29 2020-11-05 Ribon Therapeutics, Inc. Solid forms of a parp7 inhibitor
CN112745312B (zh) * 2019-10-30 2022-08-30 沈阳中化农药化工研发有限公司 哒嗪酮异恶唑甲醚类化合物及其应用
WO2021087018A1 (en) * 2019-10-30 2021-05-06 Ribon Therapeutics, Inc. Pyridazinones as parp7 inhibitors
CN116157396B (zh) * 2020-11-27 2025-07-18 康百达(四川)生物医药科技有限公司 哒嗪酮衍生物及其在医药上的应用
WO2022156708A1 (en) * 2021-01-20 2022-07-28 Jacobio Pharmaceuticals Co., Ltd. Parp7 enzyme inhibitor
CN117279917A (zh) * 2021-05-21 2023-12-22 成都百裕制药股份有限公司 哌嗪衍生物及其在医药上的应用

Similar Documents

Publication Publication Date Title
KR870001431B1 (ko) 라니티딘 염산염의 제조방법
JP2025511847A5 (cg-RX-API-DMAC7.html)
JP4138886B2 (ja) 2−アミノ−4−(4−フルオルベンジルアミノ)−1−エトキシカルボニル−アミノベンゼンの新規変態ならびにその製造法
JP2025176008A5 (cg-RX-API-DMAC7.html)
JP2015509537A5 (cg-RX-API-DMAC7.html)
JP2004534803A (ja) 1−4−(5−シアノインドール−3−イル)ブチル−4−(2−カルバモイルベンゾフラン−5−イル)ピペラジン塩酸塩の多形相
JP7257328B2 (ja) ベンゾフラン誘導体遊離塩基の結晶およびその製造方法
EP4303212B1 (en) Hydroxytyrosol nicotinamide eutectic crystal, and preparation method therefor and composition thereof
JP2024095561A5 (cg-RX-API-DMAC7.html)
JP2022523368A5 (cg-RX-API-DMAC7.html)
KR20220016949A (ko) Cdk9 억제제의 결정다형 및 이의 제조방법과 용도
CN112469717B (zh) 用于纯化艾沙康唑鎓硫酸盐的方法
CN101787069A (zh) 薯蓣皂苷元哌嗪类衍生物及其制备方法
CA2805959A1 (en) Crystals of carboprost tromethamine and the preparation method as well as the uses thereof
JP2022505670A5 (cg-RX-API-DMAC7.html)
WO2011050638A1 (zh) 一种比马前列素晶体及其制备方法和用途
JP2022540678A5 (cg-RX-API-DMAC7.html)
WO2022078122A1 (zh) 阿卡替尼的新晶型及其制备方法
JP2023523165A5 (cg-RX-API-DMAC7.html)
JP2023521631A5 (cg-RX-API-DMAC7.html)
EP3279182B1 (en) Acetylsalicylic acid derivative crystal and preparation method and use thereof
KR20230004723A (ko) 프탈라지논 화합물의 결정형
CN110156860A (zh) 一种高纯度奥贝胆酸的纯化方法
JP2022511554A5 (cg-RX-API-DMAC7.html)
CN113801021A (zh) 绿原酸钠水合物及其应用